Fenofibrate Improves Cerebral Blood Flow after Middle Cerebral Artery Occlusion in Mice

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Cerebral Blood Flow and Metabolism

• Publication date

  2010-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/jcbfm.2009.185PMID 19724288PMCID PMC2801771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice.

  2009cited by this paper
• Neuronal PPARγ Deficiency Increases Susceptibility to Brain Damage after Cerebral Ischemia

  2009cited by this paper
• Filamentous Middle Cerebral Artery Occlusion Causes Ischemic Damage to the Retina in Mice

  2008cited by this paper
• Acute Functional Recovery of Cerebral Blood Flow after Forebrain Ischemia in Rat

  2008cited by this paper
• Involvement of Phosphatidylinositol 3-Kinase-Mediated Up-Regulation of IκBα in Anti-Inflammatory Effect of Gemfibrozil in Microglia1

  2007cited by this paper
• Peroxisome proliferator‐activated receptor‐alpha is required for the neurotrophic effect of oleic acid in neurons

  2007cited by this paper
• MRI monitoring of focal cerebral ischemia in peroxisome proliferator‐activated receptor (PPAR)‐deficient mice

  2007cited by this paper
• Increased Infarct Size and Lack of Hyperphagic Response after Focal Cerebral Ischemia in Peroxisome Proliferator-Activated Receptor β-Deficient Mice

  2006cited by this paper
• PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.

  2006cited by this paper
• Peroxisomal Proliferation Protects from β-Amyloid Neurodegeneration*

  2005cited by this paper
• Peroxisomal proliferation protects from beta-amyloid neurodegeneration.

  2005cited by this paper
• Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease.

  2004cited by this paper
• WY 14643, A POTENT EXOGENOUS PPAR-α LIGAND, REDUCES INTESTINAL INJURY ASSOCIATED WITH SPLANCHNIC ARTERY OCCLUSION SHOCK

  2004cited by this paper
• Leukocyte-Endothelium Interactions during Permanent Focal Cerebral Ischemia in Mice

  2004cited by this paper
• Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease1

  2004cited by this paper
• Cerebral Microvessel Responses to Focal Ischemia

  2003cited by this paper
• Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice.

  2003cited by this paper
• Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice

  2003cited by this paper
• Peroxisome Proliferator-Activated Receptor-α Activation as a Mechanism of Preventive Neuroprotection Induced by Chronic Fenofibrate Treatment

  2003cited by this paper
• Activation of Peroxisome Proliferator–Activated Receptor-&agr; Protects the Heart From Ischemia/Reperfusion Injury

  2003cited by this paper
• Ligands of the peroxisome proliferator‐activated receptors (PPAR‐γ and PPAR‐α) reduce myocardial infarct size

  2002cited by this paper
• 17&bgr;-Estradiol Increases Rat Cerebrovascular Prostacyclin Synthesis by Elevating Cyclooxygenase-1 and Prostacyclin Synthase

  2002cited by this paper
• WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo.

  2002cited by this paper
• WY14,643, a PPARα Ligand, Has Profound Effects on Immune Responses In Vivo1

  2002cited by this paper
• Comparison of laser speckle and laser Doppler perfusion imaging: Measurement in human skin and rabbit articular tissue

  2002cited by this paper
• Agonists of peroxisome-proliferator activated receptor-alpha (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat.

  2002cited by this paper
• Delayed activation of PPARγ by LPS and IFN-γ attenuates the oxidative burst in macrophages

  2001cited by this paper
• Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages.

  2001cited by this paper
• Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT)

  2001cited by this paper
• Dynamic Imaging of Cerebral Blood Flow Using Laser Speckle

  2001cited by this paper
• Endothelial Nitric Oxide Synthase-Dependent Cerebral Blood Flow Augmentation by L-Arginine After Chronic Statin Treatment

  2000cited by this paper
• Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation

  2000cited by this paper
• Peroxisome proliferator-activated receptors: insight into multiple cellular functions.

  2000cited by this paper
• Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

  1998cited by this paper
• Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

  1998cited by this paper
• Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators

  1998cited by this paper
• Recent update on the PPARα-null mouse

  1997cited by this paper
• Recent update on the PPAR alpha-null mouse.

  1997cited by this paper
• Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

  1995cited by this paper
• Peroxisome proliferator-activated receptors: finding the orphan a home

  1994cited by this paper
• Peroxisome proliferators: paradigms and prospects.

  1993cited by this paper
• Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR)

  1993cited by this paper
• Measurement of Local Cerebral Blood Flow with [14C]Iodoantipyrine in the Mouse

  1988cited by this paper
• White blood cell plugging and blood flow maldistribution in the capillary network of cat cerebral cortex in acute hemorrhagic hypotension: an intravital microscopic study.

  1987cited by this paper
• Neuronal survival and revival during and after cerebral ischemia.

  1983cited by this paper

• Modulation of mineralocorticoid and peroxisome proliferator activated receptors in attenuating hyperlipidemia induced endothelial dysfunction and vascular dementia.

  2026cites this paper
• Fenofibrate maintains the integrity of the blood–brain barrier during cerebral ischemia–reperfusion injury by inhibiting Egr- 1

  2025cites this paper
• No-reflow after recanalization in ischemic stroke: From pathomechanisms to therapeutic strategies

  2024cites this paper
• Fasudil mediates neuroprotection in ischemia/reperfusion by modulating the ROCK-PPARα-NOX axis

  2023cites this paper
• Diindolylmethane Ameliorates Ischemic Stroke-Induced Brain Injury by Peripheral and Central Mechanisms.

  2022cites this paper
• تاثیر فنوفیبرات بر سطح پلاسمایی BDNF و مارکرهای مغزی استرس اکسیداتیو در تشنج کیندلینگ القاء شده با پنتیلن تترازول در موش کوچک آزمایشگاهی

  2021cites this paper
• PPARα Modulation-Based Therapy in Central Nervous System Diseases

  2021cites this paper
• Effect of fenofibrate on plasma level of BDNF and brain oxidative stress markers in pentylenetetrazole-induced kindling seizure in mice

  2021cites this paper
• Fenofibrate Protects against Retinal Dysfunction in a Murine Model of Common Carotid Artery Occlusion-Induced Ocular Ischemia

  2021cites this paper
• Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy during Hepatic Ischemia-Reperfusion Injury by Modulating JAK2/STAT3β/PPARα Pathway

  2021cites this paper
• Effect of fenofibrate on brain infarction, brain swelling and edema in focal-transient cerebral ischemia in rat

  2021cites this paper
• Neurovascular protection by peroxisome proliferator-activated receptor α in ischemic stroke.

  2020cites this paper
• Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy

  2020cites this paper
• Role of peroxisome proliferator‐activated receptors in stroke prevention and therapy—The best is yet to come?

  2020cites this paper
• Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice

  2019cites this paper
• The Role of Peroxisome Proliferator Activator Receptor Alpha in Cerebral Ischemia-Reperfusion Injury; a Review Study

  2019cites this paper
• Genetic Deletion of Krüppel-Like Factor 11 Aggravates Ischemic Brain Injury

  2018cites this paper
• Indole-3-carbinol improves neurobehavioral symptoms in a cerebral ischemic stroke model

  2018cites this paper
• Multifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain Injury

  2017cites this paper
• The Transcription Factor IRF6 Co-Represses PPARγ-Mediated Cytoprotection in Ischemic Cerebrovascular Endothelial Cells

  2017cites this paper
• Sex differences in the immune response to experimental stroke: Implications for translational research

  2017cites this paper
• Cerebral Blood Flow Monitoring by Diffuse Speckle Contrast Analysis during MCAO Surgery in the Rat

  2017cites this paper
• Icariin attenuates cerebral ischemia-reperfusion injury through inhibition of inflammatory response mediated by NF-κB, PPARα and PPARγ in rats.

  2016cites this paper
• Loss of PPARα perpetuates sex differences in stroke reflected by peripheral immune mechanisms

  2016cites this paper
• Neuroprotective Effects of Chronic Fenofibrate Treatment via Modulating the Immunoreactivity of Cleaved Caspase-3 in Stroke Induced by Transient Middle Cerebral Artery Occlusion Rat Model.

  2016cites this paper
• Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass.

  2016cites this paper
• Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer’s disease*

  2016cites this paper
• Protective effect of Fenofibrate in renal ischemia reperfusion injury: Involved in suppressing kinase 2 (JAK2)/transcription 3 (STAT3)/p53 signaling activation.

  2015cites this paper
• Sex differences and the role of PPAR alpha in experimental stroke

  2015cites this paper
• Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemia

  2015cites this paper
• Tesmilifene modifies brain endothelial functions and opens the blood–brain/blood–glioma barrier

  2015cites this paper
• The role of PPAR activation during the systemic response to brain injury

  2015cites this paper
• Effects of the PPAR-α Agonist Fenofibrate on Acute and Short-Term Consequences of Brain Ischemia

  2014cites this paper
• Combination therapy of betaine and fenofibrate against delayed neuronal deterioration after subarachnoid hemorrhage

  2014cites this paper
• Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic stroke

  2014cites this paper
• PPARα is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental stroke

  2014cites this paper
• Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine.

  2014cites this paper
• PPARs: a potential target for a disease-modifying strategy in stroke.

  2013cites this paper
• Repetitive cerebral blood flow measurements using laser speckle imaging in a transient cerebral ischemic mouse model.

  2013cites this paper
• Neuroprotection after cerebral ischemia

  2013cites this paper
• Cerebral Blood Flow and Oxygenation

  2013cites this paper
• Intérêt des approches pléiotropes dans l'ischémie cérébrale : modulation pharmacologique par l'atorvastatine

  2013cites this paper
• In vivo imaging of hemodynamics and oxygen metabolism in acute focal cerebral ischemic rats with laser speckle imaging and functional photoacoustic microscopy.

  2012cites this paper
• Gemfibrozil Pretreatment Affecting Antioxidant Defense System and Inflammatory, but not Nrf-2 Signaling Pathways Resulted in Female Neuroprotection and Male Neurotoxicity in the Rat Models of Global Cerebral Ischemia–Reperfusion

  2012influential citation
• New Insights into the Role of Peroxisome Proliferator-Activated Receptors in Regulating the Inflammatory Response after Tissue Injury

  2012cites this paper
• The Influence of Stroke Risk Factors and Comorbidities on Assessment of Stroke Therapies in Humans and Animals

  2012cites this paper
• Fenofibrate Improves Vascular Endothelial Function by Reducing Oxidative Stress While Increasing Endothelial Nitric Oxide Synthase in Healthy Normolipidemic Older Adults

  2012cites this paper
• 5, 8, 11, 14-eicosatetraynoic acid suppresses CCL2/MCP-1 expression in IFN-γ-stimulated astrocytes by increasing MAPK phosphatase-1 mRNA stability

  2012cites this paper
• Effects of chronic systemic treatment with peroxisome proliferator-activated receptor α activators on neuroinflammation induced by intracerebral injection of lipopolysaccharide in adult mice.

  2011cites this paper
• Peroxisome proliferator‐activated receptor‐α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function

  2011cites this paper
• Effect of fenofibrate on the experimentally induced hepatic ischemia/reperfusion injury in rats: biochemical, light, and electron microscopic studies

  2011cites this paper
• RETRACTED ARTICLE: Effect of preischemic treatment with fenofibrate, a peroxisome proliferator-activated receptor-α ligand, on hepatic ischemia–reperfusion injury in rats

  2011cites this paper
• Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels.

  2010influential citation